Another source of PF4 autoantibody production may be natural adenovirus infections, which complicate 5 to 7% of hospitalized SARS-CoV-2 patients [92,93,94] and are present in a very high percentage of hepatitis A-infected patients [95]. Here, PF4 is linked to adenoviridae infectious disease.